Method for measuring resistance or sensitivity to docetaxel
AssigneeSanofi US
InventorsDorre GRUENEBERG, Xi HUANG, Sridaran NATESAN, Paul AUGUST
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel and useful methods that predict or monitor a patient's response to a molecule of the taxoid family by measuring the increase or decrease of specific genetic markers as compared to controls. The present invention also provides kits that predict of monitor patient's response to a molecule of the taxoid family by measuring nucleic acid or protein levels of particular genetic markers and comparing their levels to controls or reference markers.
Claims22
1-31. (canceled)
A method of determining the sensitivity or resistance of a cancer cell to treatment using a molecule of the taxoid family, the method comprising the steps of:
- contacting a portion of the cancer cell with a ligand having specificity for a genetic marker;
- calculating a test level of the genetic marker based on the contacting step;
- comparing the calculated test level of the genetic marker to a reference level;
- determining the sensitivity or resistance of the cancer cell to treatment using a molecule of the taxoid family when the calculated test level of the genetic marker is lower than the reference level.
A system for providing the sensitivity or resistance of a subject or tumor to treatment using a molecule of the taxoid family, the system comprising:
- an analysis unit configured to contact, in vitro, a portion of a sample from a subject or tumor with a first ligand having specificity for a genetic marker;
- a computing device having a processor and being in operable communication with said analysis unit;
- and
- a non-transient machine readable media including a plurality of instructions executable by the processor;
- the instructions, when executed calculate a level of genetic marker, and provide the sensitivity or resistance of the subject or tumor to treatment using a molecule of the taxoid family when the calculated test level of the genetic marker is lower than a reference level of the genetic marker.
Dependencies are inferred from the claim text.